Hematology

Publications

Al-Samkari, H; Kasthuri, RS; Zhou, JY; Van Doren, LN; Mccrae, KR; Pishko, AM; Hammill, A; Lewandowska, M; Van Thillo, Q; Ibrahim, I; Byrnes, DM; Sukumar, S; Foy, P; Samuelson Bannow, BT. A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders. Expert Review of Hematology. 2026.

Ambrose, EE; Tomlinson, G; Ngoya, PS; Stuber, SE; Latham, TS; Ware, RE; Makubi, AN; Smart, LR. Persistent Splenomegaly is associated with Morbidity in Tanzanian Children with Sickle Cell Anemia: Secondary Analysis of the SPHERE Trial. Acta Haematologica. 2026; 1-18.

Ammari, O; Shah, M; Elgammal, Y; Husami, A; Kalfa, TA; Gollamudi, J. When a Trait Becomes a Disease: A Rare Hematologic Overlap of Sickle Cell Trait and Hereditary Spherocytosis. American Journal of Hematology. 2026; 101(3):601-605.

Anand, NS; Quinn, CT. NICU to neighborhood: structural drivers shape health inequities for preterm infants. Pediatric Research. 2026.

Awuonda, BO; Kiyaga, C; Chirande, L; Franklin, PC; Nnodu, OE; Ambrose, EE; Dogara, LG; Chunda-Liyoka, CM; Segbefia, CI; Zapfel, A; Berliner, N; Novelli, EM; Coetzer, TL; Ware, RE. Newborn screening results for sickle cell disease from the ASH Consortium on Newborn Screening in Africa (CONSA). Blood advances. 2026; 10(9):3200-3206.

Belton, T; Carbaugh, L; Stevens, E; Seide, A; Ferreira, B; Teng, O; Bennett, L; Pfeiffer, A; Ferreira, M; Shova, A; Niss, O; Smith-Whitley, K; Jan, S; Steinway, CM. Recruitment and retention of young adults with sickle cell disease. Health Care Transitions. 2026; 4:100133.

Betensky, M; Azzam, M; Bercovitz, R; Bhat, RV; Biss, T; Branchford, B; Brandão, LR; Chan, AKC; Faustino, EVS; Hamarsha, Q; Williams, S; Wilson, HP; Woods, G; Mustafa, RA. ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism. Blood advances. 2026; 10(12):4303-4333.

Boucher, AA; Cole, OB; Desai, PC; Donald, C; Fasipe, TA; Quinn, CT; Kennedy Lesch, J; Thompson, AA. ASH's commitment to SCD: building on 10 years of progress. Blood advances. 2026; 10(5):1518-1521.

Dorn, LE; Perry, T; Flint, K; Luchtman-Jones, L; Engel, ER. Bivalirudin Monitoring Using Dilute Thrombin Time in Pediatric Extracorporeal Membrane Oxygenation: Single-Center, Retrospective Cost Analysis, 2018-2023. Pediatric Critical Care Medicine. 2026; 27(6):714-721.

Drolet, B; Mack, J; Sisk, B; Al-Huniti, A; Chang, VY; Hammill, A; Iacobas, I; Kelly, M; Mcdermott, S; Winger, BA; Robledo, MA; Blakesley, R; Patriquin, C; Singh, S; Crary, SE. 080 ReInspire: A Phase 2 Study of Mutant-Selective PI3Kα Inhibitor, RLY-2608, in Adults and Children with PIK3CA-Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation. Journal of Investigative Dermatology. 2026; 146(3):s19.

El Kassar, N; Dezern, AE; Abkowitz, J; Artz, A; Beerman, I; Bolton, K; Brooks, MM; Borate, U; Ershler, WB; Ganz, T; White, KE; Zhang, D; Ferrucci, L; Kuchel, GA. A proposed path to explaining the unexplained anemia of aging. The journals of gerontology. Series A, Biological sciences and medical sciences. 2026; 81(1).

Eskandari, N; Pappano, E; Ruiz, MAD; Mahmud, N; Ren, G; Ivy, ZK; Gaitonde, S; Gordeuk, VR; Gladwin, MT; Malik, P; Quinn, CT; Saraf, SL. Renin-Angiotensin-Aldosterone System Inhibition Exacerbates Anemia in Sickle Cell Disease. Blood. 2026.

Fay, ME; Tandon, R; Latham, T; Lee, AJ; Rankine-Mullins, AE; Reid, M; Mitchell, CS; Ware, RE; Lam, WA. Artificial Intelligence-Based Analysis of Central Nervous System Vasculopathy in Pediatric Sickle Cell Anemia. American Journal of Hematology. 2026; 101(5):998-1004.

Forrest, J; Galea, C; Steinway, C; Teng, O; Chen, J; Jan, S; Aygun, B; Appiah-Kubi, A; Apollonsky, N; Boruchov, D; Nortey, E; Smith-Whitley, K; Trachtenberg, S; Belton, T. Community health worker support to adolescents and young adults with sickle cell disease: A multi-method analysis on transition-related support. Health Care Transitions. 2026; 4:100137.

Girgis, MK; Lopachin, TR; Hallett, TC; Briones, MA; Desai, NJ; Mcelhinney, KE; Ware, RE; Yee, MEM. Prolonged, Unintentional Overdose of Hydroxyurea in a Child With Sickle Cell Anemia. Pediatric Blood and Cancer. 2026; 73(2):e70076.

Hayward, H; Engel, E; Hammill, A; Wassmer, T; Breech, L. 164. Vascular Malformations and Gynecologic and Reproductive Health: Results From the Survey of Women with vascular Anomalies (SWAN) Study. Journal of Pediatric and Adolescent Gynecology. 2026; 39(2):322.

Hildenbrand, AK; Lang, A; Hood, AM; Bear, B; Alderfer, MA; Quinn, CT; Crosby, LE. Clinical Practice Patterns for Discussing Hydroxyurea Initiation With Families of Children With Sickle Cell Disease. Pediatric Blood and Cancer. 2026; 73(6):e70292.

Iyer, VN; Vethanayagam, D; Al-Samkari, H; Beslow, LA; Chakinala, M; Decker, JE; Faughnan, ME; Galiatsatos, P; Gane, S; Geisthoff, U; White, AJ; Zhou, J; Friday, C; Clancy, M. Letter to the editor. European Archives of Oto-Rhino-Laryngology. 2026; 283(1):599-601.

Latham, TS; Kiyaga, C; Hernandez, AG; Nakafeero, M; Kadde, N; Stuber, SE; Ndeezi, G; Aceng, JR; Ware, RE. High early mortality among Ugandan children with sickle cell anemia and congenital HIV identified by newborn screening. Blood Global Hematology. 2026; 2(2):100093.

Mckenney, KD; Kalb, LG; Hammill, AM; Comi, AM. Development and Retrospective Application of Novel Outcome Measure: Sturge–Weber Syndrome Acute Crisis (SWAC) Index. Annals of the Child Neurology Society. 2026.

Namazzi, R; Opoka, RO; Ssuuna, C; Goings, MJ; Mcelhinney, K; Datta, D; Ware, RE; John, CC; Conroy, AL. Hydroxyurea interferes with point-of-care creatinine testing in children with sickle cell anemia. BMC Research Notes. 2026.

Ntoumaziou, A; Risinger, M; Elgammal, Y; Zhang, W; Kalfa, TA; Smart, LR. Cryohydrocytosis: When Cold Breaks the Membrane. American Journal of Hematology. 2026; 101(6):1217-1219.

Power-Hays, A; Quinn, CT. Liquid Hydroxyurea (Xromi) for Children With Sickle Cell Anemia: A New Solution Compounding Existing Problems. Pediatric Blood and Cancer. 2026; 73(3):e70143.

Power-Hays, A; Mcelhinney, KE; Williams, TN; Mochamah, G; Olupot-Olupot, P; Paasi, G; Reid, ME; Rankine-Mullings, AE; Opoka, RO; John, CC; Stuber, SE; Latham, TS; Vinks, AA; Ware, RE. Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations. Blood advances. 2026; 10(2):418-427.

Quinn, CT. More disease-modifying therapies for sickle cell disease: Are small molecules and drug repurposing the way forward? Seminars in Hematology. 2026.

Quinn, CT. Intrinsic Hemolytic Anemias: Non-hemoglobinopathies. In: Classical Hematology. Springer Nature; 2026:65-78.

Rai, P; Roy, S; Arumugam, P; Konstantinidis, DG; Ponny, SR; Eiymo Mwa Mpollo, M-S; Shrestha, A; Kalfa, TA; Malik, P. Angiotensin signaling is essential for stress erythropoiesis but causes retention of dysfunctional mitochondria in RBCs. JCI Insight. 2026; 11(9).

Rineer, S; Mcgann, PT; Paschal, C; Ambrose, EE; Smart, L. Validation of a Swahili Pediatric Pain Scale in Tanzania: An Observational Study. Pain Management Nursing. 2026.

Rollins, AL; Rujumba, J; Namazzi, R; Munube, D; John, CC; Ware, RE; Apolot, D; Ssali, A; Henry, N; Opoka, RO. The role of outer setting health system factors in the use of hydroxyurea for Ugandan children with sickle cell anemia. Blood Global Hematology. 2026; 2(2):100091.

Shook, LM; Ware, RE. Advances and Gaps in Global Newborn Screening for Sickle Cell Disease. International Journal of Neonatal Screening. 2026; 12(1).

Sil, S; Mooney, JT; Adkins, TR; Sinha, C; Nunez, MA; Busbee, A; Dampier, CD; Bai, S; Crosby, LE; Thomas, S; Myer, GD; Bakshi, N; Kesar, T; Kashikar-Zuck, S. I-STRONG: An integrative, multicomponent treatment approach for chronic pain in pediatric sickle cell disease. Blood advances. 2026.

Smart, LR; Segbefia, CI; Odame, I. Creative and Adaptive Solutions for Early Diagnosis of Sickle Cell Disease in Sub-Saharan Africa. American Journal of Hematology. 2026; 101 Suppl 1(Suppl 1):17-32.

Steinway, C; Carbaugh, L; Belton, T; Teng, O; Shults, J; Bennett, L; Griffis, H; Aygun, B; Appiah-Kubi, A; Apollonsky, N; Andemariam, B; Rubin, D; Smith-Whitley, K; Jan, S. Characterizing Engagement With a Mobile Health Application Designed for Adolescents and Young Adults With Sickle Cell Disease: Findings From the COMETS Study. Pediatric Blood and Cancer. 2026; 73(6):e70252.

Ware, RE; Opoka, RO; Latham, T; Kasirye, P; Kasembo, P; Hume, H; Birungi, I; Kadde, N; Wambaka, B; Nakafeero, M; Conroy, AL; Tomlinson, G; Lane, A; John, C. Ten Years of Hydroxyurea for Ugandan Children with Sickle Cell Anemia. New England Journal of Medicine. 2026; 394(20):2059-2061.

Ware, RE. Sickle Cell Disease in Sub-Saharan Africa: Progress and Potential. American Journal of Hematology. 2026; 101 Suppl 1:3-4.

Warner, MA; Hanson, AC; Johnson, ML; Go, RS; Gajic, O; Schulte, PJ; Kor, DJ; Serra, M; Kalfa, TA; Blanc, L. Longitudinal changes in haemoglobin, iron stores, and inflammatory markers following surgery and in critical illness: an analysis from the Practical Anaemia Bundle for Sustained Blood Recovery randomised clinical trial. British Journal of Anaesthesia. 2026; 136(2):516-524.

Zhang, W; Todd, KE; Dawson, DB; Luchtman-Jones, L; Palumbo, JS. Molecular diagnosis of inherited platelet disorder via a targeted whole-exome virtual gene panel: a 5-year institutional experience. Research and Practice in Thrombosis and Haemostasis. 2026; 10(2):103413.